Global Virology Testing Market, By Procedure (Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, Hemagglutination Assays), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), Other Tests), Method (Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, Interferon's (Cytokines)), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies) – Industry Trends and Forecast to 2029.
Virology Testing Market Analysis and Size
The virology testing market is expected to grow at a significant growth rate. The new advanced molecular-based virology testing methods, such as immunoassay, mass spectrometry-based detection methods, nucleic acid-based amplification testing methods, and next-generation genome sequencing methods, are precise, quick, and provides the result for various viral infections.
Data Bridge Market Research analyses that the virology testing market which was USD 4,108.27 million in 2021, would rocket up to USD 7717.51 million by 2029, and is expected to undergo a CAGR of 8.20% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Virology Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Procedure (Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, Hemagglutination Assays), Diagnosis Test (Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), Other Tests), Method (Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, Interferon's (Cytokines)), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections), End User (Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN (Germany), Lonza (Switzerland), Sigma-Aldrich Co. (U.S.), Wuxi AppTec (China), Merck & Co. Inc. (U.S.), Eurofins Scientific (Luxembourg), General Electric (U.S.), Danaher (U.S.), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), BD (U.S.), Biospherix, Ltd (U.S.) and Novogene Co Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
Testing for viruses includes diagnostic techniques that aid in the early detection of illnesses such as hepatitis, influenza, HIV, sexually transmitted diseases, RCV, and other viruses-related diseases. Virology testing looks for the presence of viral antigens, nucleic acids, and antibodies in the provided sample. There have been identified more than 100 viral illnesses.
Virology Testing Market Dynamics
Drivers
- Rising number of patients with STDs
In the forecast period of 2022–2029, factors such as the rising number of patients with STDs, STD-related illnesses, and other viruses, as well as the availability of immune suppressive drugs and the rising number of technological advancements in the healthcare industry, are likely to boost the growth of the virology testing market. However, the development of molecular diagnostic technologies will create a number of new chances for the virology testing market to expand during the forecast period.
- Rising incidence of viral infections
The main driving factors will be the rising incidence of viral infections, the appearance of novel pathogens, and an increase in the number of product approvals. For instance, the World Health Organization (WHO) estimates that in 2021, infectious diseases affected 60% of the world's population. The demand for virology testing has increased due to the rising prevalence of viral illnesses such as human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other sexually transmitted diseases.
Opportunities
- Increased healthcare spending
The rapid adoption of cutting-edge diagnostic and testing techniques, increased healthcare spending, the existence of supportive government policies, and the presence of cutting-edge clinical laboratories and manufacturing businesses have all contributed to the region's market's robust growth over the years. An important reason for the market's expansion is the rise in R&D efforts from public and commercial organizations in the United States.
Restraints/Challenges
- Stringent regulations regarding product development and approvals
On the other hand, the stringent approval processes along with side effects of drugs and other treatment options will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the virology testing market.
This virology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the virology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Virology Testing Market
The COVID-19 pandemic has also significantly impacted the development of the segment. Nearly all diagnostic tests employ RT-PCR to screen the population who have COVID-19 symptoms because the authorities have not recommended the specific viral culture tests. To find novel compounds or leads for the treatment of COVID-19, the majority of pharmaceutical and biotechnological businesses are concentrating on research and development operations.
Recent Development
- In May 2021, In collaboration with Ubio Biotechnology Systems Pvt. Ltd., Cipla Limited introduced "ViraGen" as a polymerase chain reaction (COVID-19 RT-PCR) test for COVID-19 in India.
- In May 2022, QuantuMDx Group Limited announced the release of Q-POC SARS-CoV-2, Flu A/B & RSV Assay, a novel respiratory panel test. Rapid point-of-care testing is offered to customers through the Q-POC platform and its multiplex capabilities in clinical and non-clinical contexts.
- In January 2022, A brand-new, extremely sensitive SARS-CoV-2 Rapid Antigen Test -AQ+ Covid-19 Ag Rapid Test for usage by professionals was introduced by InTec. The AQ+ Covid-19 Ag Rapid Test is designed to be used by laypeople or medical professionals to quickly and easily detect Covid-19.
Global Virology Testing Market Scope
The virology testing market is segmented on the basis of procedure, diagnosis test, method, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Procedure
- Cell Culture Method
- Specific Antibodies Detection
- Antigen Detection
- Virus Nucleic Acid Detection
- Gene Sequencing
- Hemagglutination Assays
Diagnosis Test
- Hepatitis B
- Hepatitis C
- HIV
- Human Papillomavirus (HPV)
- Other Tests
Method
- Immunoprophylaxis
- Active Prophylaxis (Vaccines)
- Passive Prophylaxis
- Antiviral Chemotherapy
- Interferon's (Cytokines)
Application
- Skin and Soft Tissue Infections
- Respiratory Tract Infections
- GI Tract Infections
- Urinary Tract Infection
- Eye Infections
- Sexually Transmitted Diseases
- Perinatal Infections
End User
- Hospitals
- Clinics
- Laboratories
- Diagnostic Centers
- Blood Banks
- Pharmacies
Virology Testing Market Regional Analysis/Insights
The virology testing market is analysed and market size insights and trends are provided by country, procedure, diagnosis test, method, application and end user as referenced above.
The countries covered in the virology testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the virology testing market due to the technological advancement in portable diagnostics.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to advanced infrastructure development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The virology testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for virology testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the virology testing market. The data is available for historic period 2010-2020.
Competitive Landscape and Virology Testing Market Share Analysis
The virology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to virology testing market.
Some of the major players operating in the virology testing market are:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Agilent Technologies, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- QIAGEN (Germany)
- Lonza (Switzerland)
- Sigma-Aldrich Co. (U.S.)
- Wuxi AppTec (China)
- Merck & Co. Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- General Electric (U.S.)
- Danaher (U.S.)
- Sartorius AG (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- BD (U.S.)
- Biospherix, Ltd (U.S.)
- Novogene Co Ltd. (China)
SKU-